© 2021 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
September 01, 2021
The combination approach may significantly reduce over-detection while providing noninferior detection of clinically significant prostate cancer.
August 27, 2021
The algorithm is the first step towards developing an artificial intelligence-augmented radiology workflow that can support image interpretation to improve diagnosis and prognosis.
August 17, 2021
Training sets from different vendors may be required to ensure scanner-specific sensitivity.
July 23, 2021
The clear cell likelihood score can help providers determine the growth rate of masses that could be cancerous.
July 14, 2021
Including MRI leads to more quality-adjusted life years.
July 13, 2021
The potential opportunities are numerous for virtual biopsies, radiomics, and radiogenomics.
July 12, 2021
Relying on MRI images rather than PSA screening can reduce unnecessary biopsies and identification of clinically insignificant cancers.
May 25, 2021
Using a deep convolutional neural network can improve providers’ ability to predict how patients with hepatocellular carcinoma will respond to Y90-RE treatment, enabling them to offer additional therapies, if necessary.
April 25, 2021
Case Western Reserve University biomedical engineer developed a contrast agent that could allow for non-invasive disease detection.
April 04, 2021
Investigators used a hypothetical cohort of men with prostate cancer to test the benefits associated with MRI imaging before biopsy in regard to age-based and risk-stratified screening.